Bank of New York Mellon’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.24M | Buy |
615,601
+122,008
| +25% | +$444K | ﹤0.01% | 2680 |
|
|
2025
Q1 | $948K | Sell |
493,593
-3,954
| -0.8% | -$7.59K | ﹤0.01% | 3085 |
|
|
2024
Q4 | $945K | Buy |
497,547
+27,839
| +6% | +$52.9K | ﹤0.01% | 3177 |
|
|
2024
Q3 | $620K | Sell |
469,708
-134,843
| -22% | -$178K | ﹤0.01% | 3386 |
|
|
2024
Q2 | $617K | Buy |
604,551
+585,789
| +3,122% | +$598K | ﹤0.01% | 3456 |
|
|
2024
Q1 | $34.3K | Sell |
18,762
-53,069
| -74% | -$97.1K | ﹤0.01% | 4092 |
|
|
2023
Q4 | $89.1K | Buy |
71,831
+1
| +0% | +$1 | ﹤0.01% | 4102 |
|
|
2023
Q3 | $81.9K | Sell |
71,830
-6
| -0% | -$7 | ﹤0.01% | 4099 |
|
|
2023
Q2 | $65.7K | Hold |
71,836
| – | – | ﹤0.01% | 4123 |
|
|
2023
Q1 | $40.3K | Hold |
71,836
| – | – | ﹤0.01% | 4224 |
|
|
2022
Q4 | $41.4K | Hold |
71,836
| – | – | ﹤0.01% | 4265 |
|
|
2022
Q3 | $23K | Hold |
71,836
| – | – | ﹤0.01% | 4429 |
|
|
2022
Q2 | $26K | Sell |
71,836
-567,047
| -89% | -$205K | ﹤0.01% | 4460 |
|
|
2022
Q1 | $459K | Buy |
638,883
+14,038
| +2% | +$10.1K | ﹤0.01% | 3756 |
|
|
2021
Q4 | $1.41M | Buy |
624,845
+33,016
| +6% | +$74.7K | ﹤0.01% | 3187 |
|
|
2021
Q3 | $1.7M | Buy |
591,829
+29,674
| +5% | +$85.4K | ﹤0.01% | 3082 |
|
|
2021
Q2 | $2.13M | Sell |
562,155
-34,074
| -6% | -$129K | ﹤0.01% | 2941 |
|
|
2021
Q1 | $2.02M | Sell |
596,229
-61,682
| -9% | -$209K | ﹤0.01% | 2916 |
|
|
2020
Q4 | $1.84M | Buy |
657,911
+79,885
| +14% | +$224K | ﹤0.01% | 2897 |
|
|
2020
Q3 | $1.45M | Sell |
578,026
-53,282
| -8% | -$134K | ﹤0.01% | 2878 |
|
|
2020
Q2 | $8.57M | Buy |
631,308
+40,206
| +7% | +$546K | ﹤0.01% | 1924 |
|
|
2020
Q1 | $4.48M | Sell |
591,102
-101,256
| -15% | -$767K | ﹤0.01% | 2124 |
|
|
2019
Q4 | $4.38M | Buy |
692,358
+23,801
| +4% | +$150K | ﹤0.01% | 2402 |
|
|
2019
Q3 | $2.62M | Sell |
668,557
-4,317
| -0.6% | -$16.9K | ﹤0.01% | 2603 |
|
|
2019
Q2 | $3.26M | Buy |
672,874
+118,881
| +21% | +$575K | ﹤0.01% | 2547 |
|
|
2019
Q1 | $4.54M | Buy |
553,993
+5,398
| +1% | +$44.2K | ﹤0.01% | 2372 |
|
|
2018
Q4 | $3.03M | Buy |
548,595
+333,569
| +155% | +$1.84M | ﹤0.01% | 2534 |
|
|
2018
Q3 | $1.9M | Buy |
215,026
+306
| +0.1% | +$2.7K | ﹤0.01% | 2860 |
|
|
2018
Q2 | $2.14M | Buy |
214,720
+14,089
| +7% | +$141K | ﹤0.01% | 2807 |
|
|
2018
Q1 | $1.91M | Sell |
200,631
-50,762
| -20% | -$484K | ﹤0.01% | 2828 |
|
|
2017
Q4 | $3.74M | Buy |
251,393
+27,408
| +12% | +$407K | ﹤0.01% | 2486 |
|
|
2017
Q3 | $4.41M | Buy |
223,985
+24,167
| +12% | +$475K | ﹤0.01% | 2394 |
|
|
2017
Q2 | $2.87M | Buy |
199,818
+53,012
| +36% | +$762K | ﹤0.01% | 2626 |
|
|
2017
Q1 | $1.35M | Sell |
146,806
-976
| -0.7% | -$8.98K | ﹤0.01% | 3077 |
|
|
2016
Q4 | $1.54M | Buy |
147,782
+20,325
| +16% | +$212K | ﹤0.01% | 3020 |
|
|
2016
Q3 | $1.15M | Sell |
127,457
-2,518
| -2% | -$22.8K | ﹤0.01% | 3095 |
|
|
2016
Q2 | $971K | Buy |
129,975
+9,982
| +8% | +$74.6K | ﹤0.01% | 3155 |
|
|
2016
Q1 | $1.08M | Sell |
119,993
-29,370
| -20% | -$265K | ﹤0.01% | 3007 |
|
|
2015
Q4 | $1.93M | Buy |
149,363
+3,213
| +2% | +$41.5K | ﹤0.01% | 2729 |
|
|
2015
Q3 | $1.41M | Buy |
146,150
+74,596
| +104% | +$721K | ﹤0.01% | 2948 |
|
|
2015
Q2 | $736K | Buy |
71,554
+36,640
| +105% | +$377K | ﹤0.01% | 3494 |
|
|
2015
Q1 | $388K | Sell |
34,914
-25
| -0.1% | -$278 | ﹤0.01% | 3704 |
|
|
2014
Q4 | $406K | Buy |
34,939
+4,861
| +16% | +$56.5K | ﹤0.01% | 3694 |
|
|
2014
Q3 | $665K | Buy |
30,078
+1,462
| +5% | +$32.3K | ﹤0.01% | 3517 |
|
|
2014
Q2 | $795K | Buy |
+28,616
| New | +$795K | ﹤0.01% | 3428 |
|